Target intelligence / Profile preview

Solute carrier family 2, facilitated glucose transporter member 1 (GLUT1) and Solute carrier family 2, facilitated glucose transporter member 3 (GLUT3) (GLUT1 and GLUT3)

Target
GLUT1 and GLUT3
Molecular classification
Transporter, Solute carrier family, Sugar Porter family
01

Overview

Glucose transporters GLUT1 and GLUT3 are key members of the solute carrier family 2 (SLC2A) that facilitate the passive diffusion of glucose across plasma membranes [1.1.1, 1.1.3]. GLUT1 is ubiquitously expressed and serves as the primary transporter responsible for glucose delivery across the blood-brain barrier, while GLUT3 is predominantly found in neurons and possesses a high affinity for glucose to meet high metabolic demands [1.1.4, 1.3.3]. In many cancers, these transporters are significantly upregulated to facilitate the increased glucose consumption required for rapid proliferation, a phenomenon known as the Warburg effect [1.2.2, 1.2.3]. Consequently, GLUT1 and GLUT3 are prominent therapeutic targets in oncology, with various small-molecule inhibitors like BAY-876 and WZB117 being developed to disrupt tumor energy metabolism [1.3.2, 1.4.2]. Beyond cancer, mutations in the SLC2A1 gene cause GLUT1 deficiency syndrome, leading to severe neurological symptoms due to impaired brain glucose supply [1.1.2, 1.4.1]. Conversely, reduced expression of both GLUT1 and GLUT3 has been implicated in the pathogenesis of neurodegenerative disorders such as Alzheimer's disease [1.2.1, 1.3.4]. Therapeutic interventions targeting these transporters must carefully balance efficacy against the risk of systemic hypoglycemia and neuroglycopenia [1.4.1]. Additionally, GLUT1 serves as a receptor for human T-cell leukemia viruses (HTLV-I and II), adding another layer to its biological significance [1.1.2].

Other names
SLC2A1SLC2A3Glucose transporter type 1Glucose transporter type 3Erythrocyte glucose transporterNeuron-specific glucose transporterHepG2 glucose transporterSolute carrier family 2 member 1Solute carrier family 2 member 3
02

Mechanism of action

Inhibition of facilitated glucose transport, blockade of glycolytic metabolism, and chemo-radiosensitization of tumor cells [1.2.3, 1.3.2].

03

Biological functions

Glucose transportBasal glucose uptakeNeuronal energy metabolismBlood-brain barrier transportEmbryogenesisCell signaling (FGF/ERK pathways)
04

Disease associations

CancerGLUT1 deficiency syndrome (De Vivo disease)Alzheimer's diseaseEpilepsyNeurodegenerative diseaseStrokeTraumatic brain injury
05

Safety considerations

Systemic hypoglycemiaNeuroglycopeniaBlood-brain barrier transport impairmentErythrocyte dysfunctionPotential neurotoxicity
06

Interacting drugs

BAY-876

7 more in the full profile.

07

Biomarkers

GLUT1 protein expression (IHC)GLUT3 protein expression (IHC)18F-FDG PET uptakeCerebrospinal fluid-to-blood glucose ratio

Beyond the preview

Go deeper on Solute carrier family 2, facilitated glucose transporter member 1 (GLUT1) and Solute carrier family 2, facilitated glucose transporter member 3 (GLUT3) (GLUT1 and GLUT3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 2, facilitated glucose transporter member 1 (GLUT1) and Solute carrier family 2, facilitated glucose transporter member 3 (GLUT3) (GLUT1 and GLUT3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call